Croda Beauty Actives unveils Matrixyl Neolide, a breakthrough in peptide technology for optimized skincare performance.
At a time when cosmetic peptides are constantly evolving, Croda Beauty Actives presents Matrixyl Neolide. This innovation, a significant evolution of Matrixyl, uses advanced encapsulation technology to ensure precise peptide delivery and prolonged activity.
Encapsulation for optimum efficiency
Patented encapsulation technology protects Matrixyl in formulations, regulates its release within the skin (over 15 days of peptide release) and guarantees consistent performance that consumers can rely on. This enables brands to formulate products with less « formulation noise »and more predictable efficiency.
Initial clinical data show a visible firming effect in just two weeks (+25 %, p<0.01 vs. T0). Matrixyl Neolide integrates ideally into modern routines, whether professional skin care protocols or recovery care after light aesthetic treatments, showing remarkable synergy with microneedling applications (+31 % of collagen III, p<0.01 vs placebo + microneedling).
With Matrixyl Neolide, Croda Beauty Actives strengthens its position in peptide innovation, while offering brands a new opportunity to differentiate themselves with a name that is already recognized worldwide. Matrixyl Neolide contains 99.79 % of natural-origin content (according to ISO16128) and has a reduced carbon footprint (-43 %) compared to Matrixyl, while being TFA-free and RSPO and vegan-friendly.
